Printer Friendly

COMPANY INFORMATION
Innovotech Inc. 101-2011 94 St Edmonton, AB T6N 1H1 Tel: (780) 448-0585 Fax: (780) 424-0941 Contact Name Wolfgang H. Muhs Industry Biotechnology		Key Executives Ken Boutilier, CEO James Timourian, CFO Develops and utilizes technology in microbial biofilms to develop solutions to medical, agricultural and industrial problems caused by biofilms. Also provides contract research services.
FP ADVISOR COVERAGE Innovotech Inc. • FP Corporate Surveys • FP Directory of Directors • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 5/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/IOT $0.66 $1.00 $0.46 n.a. n.a. n.a. 0.5 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 1,055 n.a. $-0.05 Sept. 30/09 -15.38% 22.39% 32.77% $15,894
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 1,164 1,365 611 Net income (942) (121) (507) Total assets 3,070 2,812 809 $ $ $ Earnings per share* (0.04) (0.01) (0.04) % % % Return on equity (36.22) (8.27) (108.68)   * Common

COMPANY NEWS

Results for 'Innovotech Inc.' from past 30 days: No hits. (Links are to articles.)